Cargando…
Miro1 Impairment in a Parkinson’s At-Risk Cohort
There is a lack of reliable molecular markers for Parkinson’s disease (PD) patients and at-risk individuals. The detection of the pre-symptomatic population of PD will empower more effective clinical intervention to delay or prevent disease onset. We have previously found that the mitochondrial prot...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381147/ https://www.ncbi.nlm.nih.gov/pubmed/34434090 http://dx.doi.org/10.3389/fnmol.2021.734273 |